Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Clinical trial NCT00537940 · COMPLETED

Trial details

NCT number: NCT00537940
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Epilepsy Partial Seizure Disorder Epilepsies, Partial Complex Partial Seizure Disorder

Start date: 2008-02-01
Primary completion: 2013-07-01
Enrollment: 482

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.